| low rates of free human papillomavirus vaccine uptake among young women. | to determine uptake of quadrivalent human papillomavirus recombinant vaccine (quadrivalent; gardasil((r)), merck, new jersey, usa) offered under optimal conditions to women 18 to 24 years of age, and to identify predictors of uptake. | 2010 | 20719216 |
| knowledge and concerns related to the human papillomavirus vaccine among underserved latina women. | this study's purpose was to assess knowledge and concerns related to the human papillomavirus (hpv) vaccine among underserved latina women and latina mothers of female adolescents and to explore differences between those in the vaccinated and those in the unvaccinated groups. | 2010 | 20592548 |
| cervical cancer prevention: new tools and old barriers. | cervical cancer is the second most common female tumor worldwide, and its incidence is disproportionately high (>80%) in the developing world. in the united states, in which papanicolaou (pap) tests have reduced the annual incidence to approximately 11,000 cervical cancers, >60% of cases are reported to occur in medically underserved populations as part of a complex of diseases linked to poverty, race/ethnicity, and/or health disparities. because carcinogenic human papillomavirus (hpv) infection ... | 2010 | 20310056 |
| syncope after vaccination--united states, january 2005-july 2007. | syncope (vasovagal reaction), or fainting, can be triggered by various stimuli, including medical procedures. syncope has been documented to occur after vaccination, most commonly among adolescents, and can result in hospitalization for a medical evaluation or because of injury. during 2005 and 2006, the advisory committee on immunization practices (acip) recommended use of three newly licensed vaccines for adolescents: the quadrivalent human papillomavirus recombinant vaccine (hpv) (gardasil(r) ... | 2008 | 18451756 |